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The risk of cancer in offspring who have been exposed to diagnostic X-ray procedures while in utero has
been debated for 55 years. High doses at high dose rates to the embryo or fetus (e.g. >0.5 Gy) increase
the risk of cancer. This has been demonstrated in human epidemiology studies as well as in mammalian
animal studies. Most pregnant women exposed to diagnostic X-ray procedures or the diagnostic use of
radionuclides receive doses to the embryo or fetus <0.1 Gy. The risk of cancer in offspring exposed in
utero at a low dose such as <0.1 Gy is controversial and has not been determined.
Ó 2013 Elsevier Ltd. All rights reserved.

1. Introduction
In 1950e51, I was working in the radiation embryology section
of the University of Rochester Medical Center’s Atomic Energy
Project. We had submitted an abstract to the Anatomy Society
meetings in Detroit [1]. The completed manuscript that was submitted to Cancer Research was titled, ‘Cancer induced in rat embryos by roentgen irradiation’. The editors rejected the manuscript
and stated that if the embryos had developed cancer, there would
have been a much higher mortality. So we changed the title to
‘Neoplasia induced in rat embryos by roentgen irradiation’ and the
manuscript was accepted [2]. We examined the tumors as they ﬁrst
appeared and continued to grow (Fig. 1). Many of the tumors
became anaplastic and contained many undifferentiated cells with
a high mitotic index. At birth, most of the tumors were gone.
However, there were a few pyknotic cell remnants that were still
present. We followed 300 radiated survivors and controls for 4
years and these irradiated animals did not have a higher incidence
of cancer than the controls.
We put this project aside with the tentative conclusion that the
embryo was less vulnerable to the carcinogenic effects of low exposures of ionizing radiation than the postnatal animal.
Liane Russell [3,4] and our laboratory [5,6] had already
described ‘the all or none phenomenon’, which indicated that the
pre-somite mammalian embryo was less vulnerable to the teratogenic effects of ionizing radiation. The embryo was very vulnerable
to the lethal effects of radiation; however, the surviving embryos
did not have an increased risk of birth defects.
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When Alice Stewart published her research results, a 60-year
controversial discussion was initiated. Stewart et al. [7e10] suggested that the human embryo was more vulnerable to the leukemogenic effects of radiation and in later publications concluded
that other childhood cancers also occur more frequently in persons
exposed in utero to diagnostic radiologic procedures (primarily
pelvimetry) (Fig. 2). These authors initially estimated that a 1e2 rad
in-utero radiation exposure increases the risk of leukemia developing in the offspring by a factor of 1.5 to 2.0 over the natural
incidence. This incidence is considerably greater than the increase
resulting from 2 rad delivered to an adult population. In fact, an
increase in the incidence of leukemia after an adult population
exposure of 2 rad would be difﬁcult to document, even for very
large population groups [11,12]. Dr Stewart became a spokesperson
for anti-radiation groups. She appeared as a plaintiff expert in radiation litigation and was even a plaintiff expert against her own
country in a case before the World Court in which Ireland was suing
the UK, claiming that a British nuclear facility (Sellaﬁeld’s Fuel
Handling Plant) was contaminating the Irish sea and causing
increased cases of birth defects and cancer in the inhabitants on the
east coast of Ireland. After more than a decade of litigation the
World Court decided in favor of the UK [13]. Dr Stewart claimed
that the embryo was many times more vulnerable to the carcinogenic effects of radiation than children and she was critical of scientists who disagreed with her [8,14].
As a medical and graduate student and part-time instructor, I
did not have time to further pursue the question of the resistance of
the embryo to the carcinogenic effects of radiation. However, there
were many publications exposing animals to carcinogenic agents.
In particular, urethan (urethane; ethyl carbamate) was used by
Klein [15] and Vesselinovitch et al. [16] to produce neoplasia in
rodents. Only a few of the investigators utilizing urethan exposed
pregnant animals to this carcinogenic agent. Klein [15] reported
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Fig. 1. (A, B) Fifteen-day-old rat fetuses exposed to 1.5 Gy at day 9 post conception. The arrows in 1b are pointing to tumors under the scalp that can be seen in histological sections
in 3a, 3b, and 3c. The tumor growths are derived from outgrowths of the radiated neural tube as seen in 2a, 2b and 2c. Some of the growths dedifferentiated into more aggressiveappearing tissues (4). At the time of the birth of the fetuses almost all the growths had regressed except for a few remnants of pyknotic cells located between the brain and the scalp
(5a, 5b, and 5c). All photographs are reproduced with permission from Wilson et al. [2].

Risk of leukemia per 106 persons
following 0.01 to 0.02 Gy

that cesarean-delivered mice exposed in utero had signiﬁcantly
fewer lung tumors than animals treated postnatally. Signiﬁcantly
more tumors per lung were observed in mice injected with urethan
at 47 days of age than at birth, suggesting an increased susceptibility with age. Vesselinovitch et al. [16] exposed pregnant mice on
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Fig. 2. Risk of cancer from in-utero radiation. When Stewart ﬁrst reported the risks of
cancer in the offspring of pregnancies in which the mother had been exposed to
diagnostic radiological studies in the 1950s, the risk of leukemia was stated as one to
two orders of magnitude greater than the risk of cancer following similar exposures in
childhood. Children were believed to be slightly more vulnerable than adults. Animal
studies were inconsistent, but many of the animal studies were negative and many of
the studies did not expose the pregnant animals to doses of <0.10 Gy. ABCC, Atomic
Bomb Casualty Commission.

multiple days in mid pregnancy (days 12e18). The incidence of liver
and lung tumors was signiﬁcantly higher in mice exposed to this
carcinogen at the end of gestation. Neonatally treated animals
developed all of the tumor types more readily than those exposed
to the carcinogen in utero and also developed leukemia which did
not occur in the in-utero-exposed population. The urethan animal
studies reinforced the animal studies from our laboratory, which
indicated that the fetus had lower carcinogenic risks from mutagenic or carcinogenic agents when compared to the postnatal animal’s vulnerability.
2. Human studies concerning the vulnerability of the embryo
to the carcinogenic risks of ionizing radiation
Lilienfeld [17] reviewed the epidemiologic considerations with
respect to leukemogenesis. His results, conﬁrmed by others [18e
21] support the thesis that diagnostic radiation absorbed in utero
was associated with an increased risk of leukemia. Six of nine
studies reported in Lilienfeld’s paper indicate a 1.3e1.8-fold increase in the risk of leukemia after diagnostic radiation exposure in
utero. Lilienfeld states: ‘When one considers the variety of control
groups used and the sampling variability, the results are remarkably consistent in showing an excess frequency of leukemia among
children of radiation-exposed pregnant mothers [17].’ Diamond
et al. [22] conﬁrmed and extended the observation of a three-fold
increased incidence of leukemia in children exposed to diagnostic
radiation in utero. Interestingly, this effect did not occur in the
African-American population. When MacMahon [23] extended his
studies, the 1.5-fold excess leukemia incidence remained, but the
excess in other childhood cancers was no longer present (Table 1).
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Table 1
Risk of speciﬁc and total childhood cancers in offspring of women undergoing prenatal diagnostic X-ray procedures: caseecontrol studies.a
Reference, country, birth year

Acute lymphoblastic leukemia
Bithell and Stewart [24],c
UK, 1943e1967
Van Steensel-Moll et al. [25],
The Netherlands, 1959e1980
Shu et al. [26], Shanghai, China,
1960e1986
Magnani et al. [27], Turin, Italy
(years not provided)
Naumberg et al. [28], Sweden,
1973e1989
Shu et al. [29], USA and
Canada, 1972e1992

Acute myeloid leukemia
Bithell and Stewart [24],c
UK, 1943e1967
Shu et al. [26], Shanghai, China,
1960e1986
Van Duijn et al. [30],
The Netherlands, 1969e1979
All leukemias
Kaplan [31], California, USA,
1943e1967
Polhemus and Koch [18],
Los Angeles, California, USA
(years not provided)
Graham et al. [20], Baltimore,
Minneapolis, New York State,
USA (Tristate Study, 1969e1979)
Salonen and Saxen [32], Finland,
1945e1968
Hirayama [33], Japan, 1969e1977
Monson and MacMahon (1984)
[34],d Northeast USA, 1947e1960
Shu et al. [35], Shanghai, China,
1986e1991
Infante-Rivard et al. [36],
InfanteeRivard and Deadman [37],
Canada, 1980e1993
Rajaraman et al. [38], UK,
1976e1996
CNS tumors
Bithell and Stewart [24],c UK,
1943e1967
Salonen and Saxen [32], Finland,
1945e1968
Preston-Martin et al. [39],
Los Angeles, California, USA,
1948e1977
Monson and MacMachon [34],d
Northeast USA, 1947e1960
Bunin et al. [40], Greater Delaware
Valley, USA, 1980e1986
Schuz et al. [41], Germany,
1988e1993
Stalberg et al. [42], Sweden,
1975e1984
Rajaraman et al. [38], UK,
1976e1996
Neuroblastoma
Bithell and Stewart [24],c UK,
1943e1967

No. of cases/no.
of controls

Type of
control

Any X-ray
procedure

Estimated
RR (95% CI)b

Source of X-ray
procedure
information

Controls with
abdominal X-ray
procedures (%)

11.5

1.5 (1.3e1.8)

3.7

2.2 (1.2e3.8)

Abdominal
procedure

2007/8513

Population

517/509

Population

Interview,
medical records,
questionnaire
Questionnaire

172/618

Population

Interview

7.1

142/307

Hospital

Interview

5.5

449/450

Population

Medical records

9.8

1842/1986

Population

Interview

6 (before 1980)
2.3 (1981e1986)
1.8 (after 1986)

1.2 (0.8e1.7)
(all ages)
2.4 (1.2e5.0)
(ages 11e14
years)

866/8513

Population

11.5

1.5 (1.2e1.8)

92/618

Population

Interview;
medical records;
questionnaire
Interview

7.1

80/240

Population

Questionnaire

3

2.4 (0.8e7.0)

150/150

Friends

Interview

16

1.7 (1.1e2.7)

251/251

Hospital

Questionnaire

23.1

1.2 (0.8e1.8)

313/854

Population

Medical records

23.4

1.4 (0.9e2.3)

373/373

Population

Medical records

49.3

1.0 (0.5e1.9)

4607/5968
704/14 276

Other cancers
Hospital

Not provided
Medical records

10.6
9.4

1.6 (1.4e1.8)

166/166

Population

Interview

7.1

2.4 (0.5e10.6)

701/701

Population

Interview

1253/4857

Population

Medical records

1.2

1.4 (0.9e2.0)

1332/8513

Population

11.5

1.4 (1.2e1.7)

245/245

Population

Interview;
medical records;
questionnaire
Medical records

49.3

209/209

Friends,
neighborhood

Interview

15.0

1.3 (not provided)

298/14 276

Hospital

Medical records

9.4

1.2 (0.8e1.7)f

155 astro/32
166 PNET/321
466/2458

Population

Interview

Population

Interview

1.6 (0.9e2.8)

Pelvimetry

2.0 (0.7e3.8)
11 (not provided)

1.0 (0.6e1.7)

1.4 (0.6e3.0)

1.1 (0.8e1.6)

0.6 (0.1e5.0)

1.5 (1.2e2.0)e

0.8 (0.6e1.3)

1.1 (0.3e4.2)

1.1 (0.3e3.9)
0.8 (0.3e2.3)
0.8 (0.4e1.4)

512/524 (total CNS)
105 PNET/524
191 astro/524
482/4857

Population

Medical records;
registry

9.1

Population

Medical records

1.2

1.1
1.7
0.8
1.1

(0.7e1.6)
(0.9e3.2)
(0.4e1.5)
(0.6e1.8)

720/8513

Population

Interview;
medical records;
questionnaire

11.5

1.5 (1.2e1.8)

(continued on next page)
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Table 1 (continued )
Reference, country, birth year

Bone tumors
Bithell and Stewart [24],c UK,
1943e1967
Ewing’s sarcoma
Winn et al. (1992) [43], USA,
multicenter (years not provided)
Rhabdomyosarcoma
Gufferman et al. [44], USA,
multicenter, 1962e1988
Total childhood cancer
Bithell and Stewart [24],c UK,
1943e1967
MacMahon [45],d Northeast USA,
1947e1954
Monson and MacMahon [34],d
Northeast USA, 1947e1960
Rajaraman et al. [38], UK,
1976e1996

No. of cases/no.
of controls

Type of
control

Source of X-ray
procedure
information

Controls with
abdominal X-ray
procedures (%)

Any X-ray
procedure

Estimated
RR (95% CI)b
Abdominal
procedure

244/8513

Population

Interview;
medical records;
questionnaire

11.5

1.1 (0.7e1.7)

204/204
191/191

Population
Siblings

Interview
Interview

27.5
17.3

0.8 (0.5e1.2)
1.5 (0.8e3.2)

319/319

Population

Interview

6.8

1.4 (0.7e2.9)

8513/8513

Population

11.5

1.5 (1.3e1.6)

556/7230

Hospital

Interview;
medical records;
questionnaire
Medical records

10.6

1.5 (1.2e1.8)e

1342/14 276

Hospital

Medical records

9.4

1.3 (0.95e1.7)e

2690/4857

Population

Medical records

1.2

1.1 (0.9e1.4)

Pelvimetry

RR, relative risk; CI, conﬁdence interval; CNS, central nervous system; PNET, primitive neuroectodermal tumour.
a
Adapted from Little. [46].
b
RR and CI values are presented to one decimal place (rounded), except that one CI value is presented as 0.95 (rather than 1.0).
c
Initial Oxford Survey of Childhood Cancer CaseeControl Study (Stewart et al.10) was extended to include 12 additional birth years and an increase to 8513 cancer cases
from 1299 in the original study (Bithell and Stewart [24]). A third publication from the same investigation included cases born during 1948 to 1978 who died during 1953 to
1979 (Knox et al. [47]).
d
Initial study of MacMahon [45] was extended by Monson and MacMahon [34] to include ﬁve additional hospitals, six additional birth years, seven additional years of
childhood cancer deaths, an increase to 1 429 400 children from 734 243 in the original study.
e
Results for children who died from cancer before their 10th birthday.
f
Results for children who died from cancer before their 20th birthday; conﬁdence interval computed from data in Monson and MacMahon. [34].

Several associations of these data should be pointed out. In the
studies of Stewart and colleagues [7,10], there was a higher incidence of previous abortion in the mothers receiving pelvimetry,
and the children in the pelvimetry group had a higher incidence of
upper respiratory infections before the development of leukemia.
Others reported that infants with a strong family history of allergy
are also more susceptible to radiation-induced leukemia when
exposed to diagnostic radiation in utero. The problem with these
data is that patients with an allergic history and no exposure to
radiation had a higher frequency of leukemia than did other groups
that had received radiation in utero [48].
Of the 86 persons exposed in utero at Nagasaki, none developed
leukemia [8]. These persons received considerably higher doses of
radiation than did those patients in the previous studies.
Shiono et al. [49] examined the potential risk of diagnostic Xrays in the 44 908 pregnant patients studied in the Collaborative
Perinatal Project of the National Institute of Neurological and
Communicative Disorders and Stroke. These ﬁndings were surprising in that they reported a statistically increased relative risk for
malignancies in the offspring of mothers who were exposed before
pregnancy (preconception) [relative risk (RR): 2.61; 90% conﬁdence
limits (CL): 1.26e5.85]. However, there was no statistically signiﬁcant increase in the risk of malignant or benign tumors in the
offspring of mothers who were exposed to radiation during pregnancy (RR: 1.09; 90% CL: 0.47e2.40 for malignant neoplasms; and
RR: 0.94; 90% CL: 0.46e1.82 for benign neoplasms). Court-Brown
et al. [50] evaluated the incidence of leukemia in 39 166 offspring
of mothers who had been irradiated in utero, and Salonen [51]
studied the relationship between pregnancy radiation exposure
and childhood cancers. Neither study could establish a statistically
signiﬁcant increase in leukemia (Table 2).
Although it is true that the population of offspring exposed in
utero in Hiroshima and Nagasaki did not have an increased

incidence of leukemia and other childhood cancers during the
childhood years, they have of course developed cancer as adults
(Fig. 3).
A larger number of cancers must accumulate before we can
reliably establish a risk of cancer in adults who were exposed in
utero. Whether there is an increased risk has been partially
answered by Preston et al. [67] One conclusion is certain: the risk of
developing cancer as an adult from in-utero radiation is below the
risks of childhood cancer that have been suggested by several investigators (Fig. 4) [7e10,17e19,21].
Hoshino et al. [68] reported no increase in leukemia in a study of
17 000 children of parents who had received radiation before
conception. The question arises as to what extent the same biases
that contribute to the increased risk of leukemia in the cases of
radiation exposure before conception also affect the in-utero radiation cases. Graham et al. [20] pointed out that children of
mothers with a history of abortion or stillbirths also had children
with a higher risk of leukemia.
Miller [69] and others [56,70,71] do not believe that the risk of
prenatal radiation is as great as Stewart suggests. Miller writes:
It is surprising that in Stewart’s studies minimal doses of x-rays
are equally oncogenic whether exposure occurred before
conception or during pregnancy, whether the neoplasm studied
was leukemia or any other major cancer of childhood, and
whether the study was based on interviews, which may be
biased, or from hospital records. Taken in aggregate, the similarity of results, in the absence of a doseeresponse effect or of
supporting data from animal experimentation, raises a question
about biologic plausibility of a causal relationship.
Furthermore, Miller [69] points out that siblings of leukemic
children have a risk of childhood leukemia of 1 in 720 in the ﬁrst 10
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Table 2
Cancer mortality rates in cohorts of children whose mothers underwent diagnostic
X-ray procedures during pregnancy.a
Reference, location

No. of cancer deaths;
no. of children
exposed in uterob

Murray et al. [52]
(Rochester, NY)
Court Brown et al. [50]
(Edinburgh)d
Lewis [53] (London)
Griem et al. [54]
(Chicago)
Oppenheim et al.
[55,56] (Chicago)e
Diamond et al. [22]
(Baltimore)
Shiono et al. [49]
(USA, multicenter)
Golding et al. [57]
(UK, national)
Combined small
cohorts (ICRP [58])
Dempster [59]
Milis et al. [60]
Lejeune et al. [61]
Magnin [62]
Nokkentved [63]
Hagstrom et al. [64],h
Ray et al. [65]
(Ontario, Canada)

3 (L); w6740c

0.9 (0.3e3.1)

9 (L); 39 166

0.9 (0.4e1.6)

a

1 (L); 11 443
4 (I L, 3 O); 982

Total cancer
[RR (95% CI)]

1.2 (0.4e4.0)

1 (L); 393

Leukemia
[RR (95% CI)]

0.4 (0.1e2.6)
0.4 (0.1e2.6)
0.7 (0.1e5.0)

13 (6 L, 7 O); 19 889

1.1 (0.5e2.1)

7; w5000f

1.1 (0.5e2.4)

12; w3000g

1.2 (0.6e2.5)

7

4.6 (0.9e25.1)

[0; 148]
[0; 190]
[2; 491]
[1; 5353]
[0; 152]
[4; 649]
4; 5590

0.7 (0.3e1.8)

1.6 (0.6e4.6)

Adapted from Doll and Wakeford [66] and ICRP. [58].
The number of leukemias (L) and other cancers (O) are given when available.
c
A total of 140 438 children aged <20 years were included; w6460 of the 6740
exposed mothers had pelvimetry or other abdominal X-ray procedures during
pregnancy.
d
Doll pointed out his concerns about the adequacy of the identiﬁcation of irradiated women that arose when he tried to extend the Court Brown et al. [50] study.
Doll indicated that some of the ﬁndings may therefore be unreliable (Doll and
Wakeford [66]).
e
Subsequent follow-up study of Griem et al. [54].
f
A total of 55 908 live births were studied; w10% of the mothers had abdominal
X-ray procedures during pregnancy.
g
A total of 16 193 live births were studied; w18% of the mothers had abdominal,
non-abdominal or dental X-ray procedures during pregnancy.
h
Exposure in Hagstrom et al. [64] was to radioactive iron (59Fe) administered
during pregnancy. The RR and 95% CI for this small cohort was 6.1 (1.7e15.8).
b
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years of their life, which is greater than the 1:2000 risk of leukemia
after pelvimetry exposure and the 1:3000 probability of leukemia
in the general population of children followed for 10 years (Table 3).
Stewart and Kneale [7] reinforces the contention that radiation may
not be the only etiologic factor responsible for the induction of
malignancy because of unirradiated siblings of the irradiated patient population with a higher incidence of leukemia also had an
incidence higher than in control siblings and in control patients.
This observation certainly would indicate that genetic or other
environmental factors may be important in the etiology of
leukemia.
At present, some investigators believe that in-utero exposure to
small amounts of radiation increased the risk of leukemia and other
malignancies, whereas others seriously question the contention
that the embryo is markedly more sensitive to the leukemogenic
effects of irradiation when compared with the child or adult. Until
the mechanism is understood, there will be doubt concerning the
magnitude of the role of in-utero diagnostic radiology studies in
leukemia induction. The increased incidence of cancer in children
exposed to in-utero diagnostic radiation should be clariﬁed in view
of the fact that much higher doses of radiation to animal embryos
and to the children exposed in utero at Hiroshima and Nagasaki
have not resulted in a marked increase in the incidence of cancers
from higher doses of radiation, which one would expect if the
embryo were as sensitive to the carcinogenic effects of radiation as
Stewart and colleagues suggest (Table 2) (Figs. 3 and 4) [74e77].
One cannot overemphasize either the importance of the multiplicity of factors or the difﬁculties involved in identifying and controlling for such factors. Even laboratory experiments concerned
with tumor production are difﬁcult to interpret. For example, Ross
and Bras [48] reported that the incidence of spontaneous tumors
varied with the diet and weight of the animals. Heavier animals on
high-protein diets had a higher incidence of tumors than did the
lighter rats on low-protein diets. Hence, there are many unanswered
questions pertaining to the relationship between leukemia and
malignancy and in-utero radiation exposure.
Because of the introduction of new diagnostic techniques, such
as the use of ultrasound, and because of the concerns about the
risks of radiation, fewer pregnant patients will be exposed in the
future. Therefore it is unlikely that adequate numbers of exposed
patients will be available to evaluate the carcinogenic risks of inutero diagnostic radiation. MacMahon [21] in his editorial in the

Fig. 3. Solid cancer risk patterns for in-utero and childhood exposures e atom bomb survivors. The graphs indicate that there is a clear and signiﬁcant difference in the risk of tumor
development in the embryo-irradiated and childhood-irradiated populations. During the course of the 55 year post-radiation period tumors are accumulating at a much lower rate
in the irradiated in-utero population. ERR, excess relative risk; PY, person-years; CI, conﬁdence interval. Reproduced with permission from Preston et al. [67].
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Fig. 4. Risk of leukemia in children following radiation exposure during pregnancy.
This graph illustrates the modiﬁcation proposed for Fig. 2, which indicates that the risk
of leukemia from radiation of the embryo/fetus is not one to two orders greater than
for the child, but actually lower than the risk for the child.

New England Journal of Medicine wrote that ‘It seems likely that the
question of the association between fetal irradiation and childhood
cancer will fade into medical history unresolved and remain a
source of more confusion than enlightenment.’
There is little disagreement with the concept that radiation may
represent a carcinogenic risk to the embryo and adult and that
there may be different risks per rad at different stages of development. The concept that is difﬁcult to explain from a basic science
viewpoint is, ‘Why would embryonic cells be orders of magnitude
more sensitive to radiation-induced cancer than cells of children or
adults?’
Recent publications have provided added perspectives, data,
and interpretations of the prior publications [78e86]. Boice and
Miller [78] point out that numerous epidemiologic studies have
been performed. Positive associations for an increased incidence of
cancer after in-utero diagnostic radiation exposures have been
derived almost exclusively from caseecontrol studies (Tables 1e3),
whereas almost all of the cohort studies have found no association
(Figs. 3 and 4). It is of great interest that the in-utero atomic bomb
population did not demonstrate an increase in childhood leukemia

despite the fact that many in the in-utero population were exposed
to high doses of acute irradiation.
Because many of the positive associations have been derived
from caseecontrol studies, the questions of confounding factors
have been raised to explain the ﬁndings. Twin studies have been
used to eliminate some of the confounding factors [87e89].
Although the reports of Mole [89] and Harvey et al. [87] were
positive, the Rodvall study [88] was not statistically signiﬁcant.
The most recent estimates of the carcinogenic risk of in-utero
radiation have moved from two extremes. The ﬁrst viewpoint
popularized by Stewart [8,10] suggested a risk of one or two orders
greater than the carcinogenic risk of postnatal exposure to children
and adults. Based on animal data and the Radiation Effects Research
Foundation (RERF) data, it appeared that the embryo and fetus may
actually have a lower risk than children exposed postnatally. Boice
and Miller [78] have concluded that the more recent data have
reduced the discrepancy between these two extreme viewpoints.
Based on the reports of Muirhead and Kneale [82] and Mole [89]
they believe that ‘The risk estimate associated with intrauterine
radiation is not substantially greater than that seen following
childhood irradiation.’
Doll and Wakeford [90] expressed their opinion about the
carcinogenic effect of intrauterine radiation and concluded that
‘Irradiation of the fetus in utero increases the risk of childhood
cancer, and increases the risk from exposures of the order of 10 mGy,
and that in these circumstances the excess risk is w6% per Gy.’
The atomic bomb survivors of in-utero irradiation have been
followed into adulthood, and the incidence of cancer in this population has been studied [86]. Although some of the exposures to
this population of pregnant women was considerably higher than
the exposure from the population exposed to radiation from
pelvimetry, there was only a small excess of adult tumors among
the atomic bomb survivors exposed in utero (Tables 2 and 3).
Boice and Miller [78] conclude:
Learned debate continues as to the causal nature of low level
intrauterine radiation and subsequent cancer risk. The association is not questioned, but the etiologic signiﬁcance is. Different
scientists interpreting the same data have different opinions as
to the causal nature of the association and the possible level of
risk.

Table 3
Risk of leukemia.a
Group

Risk

Latency

Identical twin of a leukemic twin
Radiation-induced polycythemia
Bloom syndrome
Hiroshima survivors <1000 m
hypocenter
Down syndrome
Radiation treatment of ankylosing
spondylitis
Siblings of a leukemic child
Combined background risk of
leukemia plus radiation risk
from Stewart
Additional risk of in-utero
diagnostic radiation studies
(Stewart et al. [8])
In-utero diagnostic radiation
(RERF) data and other cohort
studies

1:5
1:6
1:8
1:60

Weeks to months
10e15 years
<10 years of age
3e12 years

1:95
1:270

Weeks to months
15 years

1:720
1:2000

10 years
10 years

1:6000

10 years

Risk the same for
exposure during
childhood but
actual risk is
uncertain (Miller
[72]; Brent [73])
1:3000

Lifetime

US Caucasian aged <15 years

RERF, Radiation Effects Research Foundation.
a
Modiﬁed from Miller et al. [69].

10 years

Box 1
Arguments supporting a causal association between prenatal
radiation and childhood leukemia and cancer

1. Consistency. Practically all studies are statistically
consistent, with relative risk of 1.40 for leukemia
[23,66,91].
2. Dose response. Risk of childhood cancer was found to
increase with number of X-ray films [68].
3. Coherence. Apparent lower risk of childhood cancer in
birth cohorts born in years when dose per film was lower
[66,92].
4. Recall bias is unlikely to be a major factor [45].
5. Confounding variables have been sought, but none has
been found [68,34].
6. Selection bias related to reason for radiographic examination is not supported by caseecontrol studies of twins
[87,89].
7. Risk estimates after intrauterine exposures are generally
comparable to risks after childhood exposures for leukemia [82,91].
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Box 2
Grounds for uncertainty regarding the causal nature of the association between prenatal radiation and childhood cancer

1. Atomic bomb in-utero study finds no excess of childhood
cancer deaths [93], whereas a lower limit of 5.2 extra
cancer deaths was predicted from the risk model based
on obstetric X-ray data [7]. The central estimate of excess
cancer deaths predicted was about 10.
2. All major cohort studies are negative [22,50,91].
3. Biological implausibility; the equality of relative risks
associated with obstetric X-rays for leukemia and solid
tumors is perplexing given the variability in tissue
radiosensitivity, dissimilar origins, and different incidence patterns [94,95]. The extended MacMahon study
did not find an increased risk for solid cancers [34].
4. Risk estimates appear greater for in-utero versus
newborn exposures, for solid cancers [91].
5. Twin cohorts have lower risk of childhood cancer than
singletons despite more frequent X-rays [91,96,97].
6. Supporting animal evidence is weak [95,98,99].

Boxes 1 and 2 summarize the opinion of John Boice and Robert
Miller regarding the controversy pertaining to the carcinogenic risk
of ionizing radiation exposure to the developing embryo following
the National Council on Radiation Protection and Measurements
(NCRP) annual meeting dealing with the developmental, reproductive, carcinogenic and mutagenic risks of ionizing radiation
published in 1999 [78].
During the period from 1997 to 2013 there were other publications dealing with the carcinogenic risk of exposing the embryo
to ionizing radiation besides Boice and Miller [78], the RERF program in Japan [67] and the publications of Wakeford
[66,90,100,101]. Wakeford continued his estimate of the risks of
cancer following in-utero radiation and persisted with the
conclusion that the embryo was more vulnerable to the carcinogenic effects of ionizing radiation than the risks in exposed
children.
The most important recent publication dealing with the carcinogenic risks of in-utero radiation was that by Preston et al. [67]
ICRP 90 was published in 2003 and was titled ‘Effects of prenatal
irradiation (embryo and fetus)’. In 2013 an update of NCRP Handbook 54 was published as NCRP Report 174, ‘Preconception and
prenatal radiation exposure: health effects and protective guidance.’ [102] Dr Martha Linet had ﬁnal responsibility for the section
on oncogenesis. Contributions and suggestions were submitted by
other committee members to Dr Linet. Dr Roy Shore’s critiques
from the RERF program in Japan were particularly helpful.
Before reviewing the Preston et al. [67] the data pertaining to
the caseecontrol and cohort studies are examined.

2.1. Caseecontrol and cohort studies
Alice Stewart and her colleagues were the ﬁrst to indicate that
diagnostic radiological studies of pregnant women could signiﬁcantly increase the risk of cancer in the offspring [9,10]. Similar
caseecontrol studies were performed in eight other countries and
they are summarized in Table 1. Some investigators were skeptical
of Dr Stewart’s conclusions because the results were partly based
on medical histories obtained from the mother rather than from the
medical records. However, later analyses utilized primarily medical
records and the increased RR > 1.0 persisted. Attempts to determine the actual fetal exposure of the pregnant women were not
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successful, since the exposures were never measured on the
pregnant women whose offspring were part of the analysis.
There are 35 caseecontrol studies listed in Table 1 dealing with
childhood lymphoblastic leukemia, acute myeloid leukemia, all
leukemias, CNS tumors, neuroblastoma, bone tumors, Ewing sarcoma, rhabdomyosarcoma and total childhood cancer. Twenty-ﬁve
of the caseecontrol studies were not statistically signiﬁcant. Ten of
the studies with RR > 1 were statistically signiﬁcant. The consensus
was that the caseecontrol studies supported a RR of 1.2e1.3 based
on a meta-analysis [101].
3. Epidemiological cohort studies (Table 2)
There were 17 cohort studies of the offspring of women who had
been exposed to radiation during their pregnancy. None of the
studies individually reported a statistically increased RR for cancer
in the offspring. Cohort investigations to assess childhood cancer
risks among those undergoing diagnostic X-ray procedures
involving in-utero exposure included radiation-exposed populations ranging in size from <200 to nearly 40 000 children. The
largest cohort study in this group was the report of Court Brown
et al. [50] This article was published in 1960 just a few years after
Giles et al. [9] and Stewart et al. [10] had indicated that the embryo
may be much more vulnerable to the carcinogenic effects of radiation. There were 39 166 exposed and more than 1.5 million unexposed. There were nine leukemia subjects in the radiated
population and 14 in the controls [RR: 0.9; 95% conﬁdence interval
(CI): 0.4e1.6]. None of the cohort studies was statistically signiﬁcant. The problem of cohort studies is that very large populations of
exposed individuals are needed, which was not the case with most
of these cohort studies.
4. Environmental exposures: atomic bomb survivors (Preston
et al. [67])
Although there was no evidence of a dose-related increase in
cancer mortality at ages prior to 15 years of age among the w2500
persons who were in utero at the time of the bombings [103], as the
cohort has grown older, a statistically signiﬁcant excess relative risk
(ERR) of solid cancers became apparent (ERR: 2.1 Gye1; 90% CI:
0.2e6.0), based on 10 deaths among those with weighted uterine
doses >0.01 Gy [80]. In a follow-up of cancer mortality risks during
1950 to 1992 comparing risks among a subset of persons who were
in utero versus those who were 0 to <6 years of age at the time of
the bombings, there were only two deaths from leukemia (both
exposed to relatively low doses and none during childhood) in the
in-utero cohort versus 24 among children <6 years of age at
exposure (Fig. 3) [80].
Subsequently, Preston et al. [67] compared solid cancer incidence risks among in-utero cohort members aged 12e55 years
during 1958 to 1999 (based on 94 cancers) with risks among survivors who were aged <6 years of age at the time of the bombings
(based on 649 cancers). The difference in ERRs and excess absolute
risks (EARs) between the two cohorts suggests that lifetime cancer
risks at age 50 years following in-utero exposure are lower than
risks for early childhood exposures. However, the investigators
state, ‘Additional follow-up of this cohort is necessary before
deﬁnitive conclusions can be made about the nature of the risk for
those exposed in utero’ [67] (Figs. 3 and 4). The difference in ERRs
and EARs between the two cohorts suggests that lifetime cancer
risks at 50 years of age following in-utero exposure are lower than
risks for early childhood exposure.
However, the investigators state that ‘additional follow-up of
this cohort is necessary before deﬁnitive conclusions can be made
about the nature of the risks for those exposed in utero.’67 The
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investigators also note that ‘this study cannot provide information
on the effect of radiation on the incidence of childhood cancers
because comprehensive data on solid cancer incidence are unavailable for the period from 1945 to 1957.’ Mortality follow-up for
the in-utero cohort, however, was available from 1950 and indicated no deaths from childhood leukemia [80]. Another limitation
is the small numbers of cancers in each dose category in the inutero cohort.
Nevertheless, this investigation is the only cohort study with
long-term, continuous, active follow-up of a population with inutero radiation exposure and high-quality estimated doses for
each subject.
5. Animal studies
Many animal studies were performed in which pregnant animals were irradiated with ionizing radiation and the risk of cancer
in the offspring was evaluated in the offspring. A major problem
with these studies is that very few of the protocols utilized exposures in the diagnostic range of clinical X-ray studies (<0.10 Gy). So
very few of the studies were planned to answer the question of the
risk of diagnostic radiation to pregnant women.
Several studies have reported excess risks of various tumors in
mice after in-utero irradiation, mostly after whole-body doses
higher than 2 Gy. Offspring of BC3F1 mice who received wholebody in-utero doses (17th day post coitus) ranging from 0.3 to
2.1 Gy (41e58 animals in each dose group) developed small increases in liver tumor occurrence [104]. Offspring of B6C3F1 mice
exposed to a whole-body dose of 3.8 Gy in utero developed
increased risk of pituitary, ovarian, liver, and bone tumors; an increase in lung tumors was statistically signiﬁcant after doses of 1.9,
3.8, and 5.7 Gy; and an elevation in malignant lymphoma, lymphocytic type, was statistically signiﬁcant after 5.7 Gy [105].
In-utero irradiation [0.3 and 1 Gy (X-rays, whole body)] during
day 10.5 postconception (PT  HT F1) did not induce an increased
incidence of neoplasms in the offspring [106].
Studies assessing tumor risks in different strains of mice
demonstrate high susceptibility of the ovaries for radiation-related
tumor induction during the fetal period, with 0.25 Gy the lowest
dose associated with a statistically signiﬁcant increase
[105,107,108].
Other investigations found no excess cancer after in-utero
irradiation of mice with 3 or 2 Gy [99,109], although each of
these studies showed increased risks of cancer in the mice
following administration of similar doses postnatally. Although
investigators found no excess cancer in BC3F1 mice after
in-utero exposures to 0.3 Gy, increased risks were seen in mice
given the same dose postnatally [84].
Rugh et al. [110] in a very large study irradiated mice with 1 Gy
on each day post conception and observed the incidence of tumors
in the offspring as adults. There was no statistically signiﬁcant increase in the incidence of tumors in adult animals from irradiation
in utero on any day. Brent and Bolden [6] exposed pregnant mice to
doses of 0.3, 0.6, and 0.9 Gy at 0.5, 7.5, 8.5, 12.5, and 16.5 days post
conception. They also did not observe an increase in the incidence
of tumors. However, the pre-sexually mature mouse was more
vulnerable than the adult mouse to the leukemogenic effect of
radiation.
Offspring of pregnant beagles treated with mean doses of 0.16 or
0.81 Gy at 8th, 28th, or 55th days post coitus (120 dogs in each dose
and treatment day group) experienced increases in mortality from
total cancers that were not statistically signiﬁcant, and statistically
signiﬁcant elevated mortality risks from lymphoma. Detailed
assessment revealed that the increased risk of fatal neoplasms was
most pronounced in beagles irradiated in the neonatal period [111].

These data suggest that irradiation in both the fetal and neonatal
periods are associated with an increase of early onset and lifetime
cancer risk. However, the lower-dose group (0.16 Gy) did not have
an increased incidence of tumors.
Warkany et al. [112] studied the interaction of ethylnitrosourea
and X-irradiation in rats. The original goal of the investigators was
to determine the effect of X-irradiation administered on the 16th
day post conception on the incidence of tumors following the
administration of ethylnitrosourea on the 20th day post conception.
Sixteen months after delivery 62.2% of the rats that had received
only the ethylnitrosourea during the fetal period had neurogenic
tumors. After fetal irradiation on the 16th day post conception,
followed by ethylnitrosourea 4 days later, 16.7% of the rats developed neurogenic tumors. The mechanisms of these unexpected
ﬁndings, whereby irradiation before receiving an oncogenic drug
reduced the incidence of cancer, have not been determined.
Nakano et al. [113] irradiated mice at various stages of pregnancy with 1 or 2 Gy. Translocation frequencies in the peripheral
blood T-cells, spleen cells, and bone-marrow cells were determined
when the offspring were aged 20 weeks. The translocation frequency was very low in the mice that were irradiated in utero
(0.8%). The mice irradiated during days to weeks after birth had
translocation frequencies of 5%. The authors suggested that the
abnormal cells in the fetus were replaced by normal fetal stem cells
during the postnatal growth of the animal. If this phenomenon
occurs in humans, it could explain why the fetus may be less
vulnerable to the oncogenic effect of radiation than the child.
Earlier research supporting the ﬁndings of Nakano et al. [113] found
that X-irradiation of the rat embryo during early organogenesis
resulted in the production of hundreds of small growths that
resembled well-differentiated ependymomas or retinoblastomas
(Fig. 1) [1,2]. As the embryo developed, some of the tumors dedifferentiated into more primitive growths. However, at term almost
all the cytogenetically abnormal cells had regressed e similar to the
result reported by Nakano et al [113].
6. Counseling patients about the in-utero carcinogenic risks
of ionizing radiation
Although it is our opinion that a dose of <0.10 Gy to the
implanted embryo does not result in a signiﬁcant increase risk for
congenital malformations, intrauterine growth restriction, or fetal
death (deterministic effects), low-risk tumorigenic or genetic hazards cannot be ruled out. Even if one believed that the tumorigenic
(leukemogenic) effects of low-level radiation were real, let us
examine how difﬁcult it would be to use this information in
counseling a patient who has received a dose of perhaps 2 rad
(0.02 Gy) during her pregnancy. According to Stewart et al. [7,8,10],
the risk of leukemia after this exposure in utero is 1:2000 versus
1:3000 in unexposed controls over a 10-year period (Table 3). If one
were inclined to recommend therapeutic abortion for this pregnancy because the probability of developing leukemia is 50%
greater than controls, one would perform abortions in almost 2000
exposed non-leukemic subjects for every leukemic subject ‘saved’.
It is one thing to avoid radiation because of a potential or conjectured hazard, but it is another matter to recommend therapeutic
abortion on this basis. If a physician were inclined to accept this
increased probability (1:2000) as a risk great enough to recommend therapeutic abortion, he or she would be placed in a serious
dilemma because there are other epidemiologic situations in which
the risk of leukemia is greater. In fact, the hypothetical incremental
risk for 2 rad of in-utero radiation is 1:6000 over a 10-year period. It
is the combination of the control risk plus the incremental radiation
risk that results in a 1:2000 risk for these patients. From Table 1 it
should be clear that the risk of leukemia is greater in ‘unirradiated’
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siblings of leukemics (1:720) than in patients subjected to diagnostic radiation (1:2000) if one uses Stewart’s risk estimate.
Certainly, the position that all future pregnancies of parents
with one leukemic child should be aborted would be untenable.
One can carry this argument to its ridiculous extreme by advocating
that all pregnancies should be aborted because of the risk of serious
malformations is w30 per 1000 deliveries (Table 3) and this does
not include the probability of postnatal diseases occurring in these
offspring. Some may interpret this as a facetious discussion, but the
clinician and the patient must recognize that ‘spontaneous’ risks of
pregnancy are two orders of magnitude greater than the theoretical
risks of diagnostic radiation (Box 1).
7. Conclusions and counseling advice
The radiation risks determined from the A-bomb exposure to
the populations in Hiroshima and Nagasaki have been referred to as
the "gold standard" for determining radiation risks because the
study was a large cohort study with a major effort to determine the
actual exposure of each survivor. Yet we know that if individuals or
populations are exposed to x-rays or gamma rays of different
photon energy or length of exposure, the risks may deviate from
the risks determined for the A-bomb survivors. Furthermore, there
was a neutron component in the radiation from the A-bomb detonations. So one can assume that exposures to the embryo from an
IVP or ﬂuoroscopy in a pregnant mother may represent a different
risk to the embryo per mGy than the A-bomb data. So that is why it
is problematic to provide deﬁnitive carcinogenic risks for diagnostic radiologic studies utilizing x-rays or radionuclides. This
article has discussed the subject of the carcinogenic risk of ionizing
radiation to the embryo.
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radiation. However, I would predict that in the next 20 years
we will learn that the risk of cancer from embryonic radiation will be further reduced from the ﬁndings of the Preston
et al. 2008 study. At my present age I will not be alive to
know the results. I believe that the omnipotential (stem)
cells protective effect that was present in the embryo at the
time of the radiation will continue to be manifested.

7.1. Counseling an individual patient
If a pregnant woman has had a diagnostic radiological procedure that exposed her embryo or who has been scheduled for an Xray that will expose her embryo and is concerned about the
increased risk of cancer from the exposure, how should a counselor
respond?
The majority of diagnostic radiological studies expose the
embryo to <0.10 Gy (<10 rad) which is a very low exposure. Based
on all the studies we have available, the risk of cancer to the embryo
is very low and possibly so low that we may never be able to
measure the risk. Therefore, diagnostic radiological studies that are
considered to be important for optimal patient care should be
performed. It is important to be aware of the background risk of
cancer for all individuals, which is 23% for potentially lethal cancers. Fortunately, each year the percentage of cancers that are cured
is increasing. The background risk of cancer is hundreds or more
times the theoretical risks of diagnostic radiological exposures to
the embryo.
Conﬂict of interest statement
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1. There is no doubt that if the exposure is high enough and of
short duration, the carcinogenic risks are increased. Protracted
continuous radiation of 0.02 Gy/day does not represent an
increased carcinogenic risk. Acute radiation of 1.0 Gy at midgestation does represent an increased carcinogenic risk.
2. The embryo is less vulnerable to the carcinogenic effects of radiation the earlier in gestation it is exposed.
3. There are at least three viewpoints on the carcinogenic risks of
<0.10 Gy embryonic radiation.
(a) There is the scholarly, conservative view of Martha Linet
who writes that the risk is very small and would not justify
canceling a radiological study in a pregnant woman if the
study is medically indicated. She also suggests that we wait
to determine whether the risk increases based on future
data from the Preston et al. study, which stated that ‘additional follow-up of this cohort is necessary before deﬁnitive
conclusions can be made about the nature of the risks for
those exposed in utero.’ [67]
(b) Richard Wakeford has been interested in this subject for
decades. We ﬁrst met many years ago when we were defense experts in litigation between the UK and Ireland
regarding the allegation that the Sellaﬁeld Nuclear Facility
was discharging nuclear ‘waste’ that was responsible for an
increase in cancer and birth defects in the inhabitants on the
East Coast of Ireland. The World Court deliberations ended
after 10 years with a defense verdict. Wakeford’s views have
changed with time. One of his most recent publications indicates that he believes that 20% of childhood leukemia in
the UK is due to background radiation [114]. He still is the
proponent of the idea that the embryo is more vulnerable to
the carcinogenic effects of radiation than the child.
(c) I am not one who is reluctant to make predictions. I agree
with Martha Linet regarding the risks of embryonic ionizing
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